Kristin L. MacArthur

Beth Israel Deaconess Medical Center, Boston, MA, United States

Are you Kristin L. MacArthur?

Claim your profile

Publications (2)2.37 Total impact

  • Source
    Kristin L. MacArthur · Robert Smolic · Martina V. Smolic · Catherine H. Wu · George Y. Wu
    [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis C virus (HCV) infects nearly 170 million people worldwide and causes chronic hepatitis, cirrhosis, and hepatocellular carcinoma. The search for a drug regimen that maximizes efficacy and minimizes side effects is quickly evolving. This review will discuss a wide range of drug targets currently in all phases of development for the treatment of HCV. Direct data from agents in phase III/IV clinical trials will be presented, along with reported side-effect profiles. The mechanism of action of all treatments and resistance issues are highlighted. Special attention is given to available trial data supporting interferon-free treatment regimens. HCV has become an increasingly important public health concern, and it is important for physicians to stay up to date on the rapidly growing novel therapeutic options.
    Preview · Article · Aug 2013
  • Source
    Kristin L MacArthur · Catherine H Wu · George Y Wu
    [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis C virus (HCV) hepatitis, initially termed non-A, non-B hepatitis, has become one of the leading causes of cirrhosis and hepatocellular carcinoma worldwide. With the help of animal models, our understanding of the virus has grown substantially from the time of initial discovery. There is a paucity of available animal models for the study of HCV, mainly because of the selective susceptibility limited to humans and primates. Recent work has focused modification of animals to permit HCV entry, replication and transmission. In this review, we highlight the currently available models for the study of HCV including chimpanzees, tupaia, mouse and rat models. Discussion will include methods of model design as well as the advantages and disadvantages of each model. Particular focus is dedicated to knowledge of pathophysiologic mechanisms of HCV infection that have been elucidated through animal studies. Research within animal models is critically important to establish a complete understanding of HCV infection, which will ultimately form the basis for future treatments and prevention of disease.
    Preview · Article · Jun 2012 · World Journal of Gastroenterology

Publication Stats

10 Citations
2.37 Total Impact Points


  • 2012
    • Beth Israel Deaconess Medical Center
      • Department of Medicine
      Boston, MA, United States